Kedar Inamdar

1.1k total citations
39 papers, 772 citations indexed

About

Kedar Inamdar is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Kedar Inamdar has authored 39 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Kedar Inamdar's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (5 papers). Kedar Inamdar is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (5 papers). Kedar Inamdar collaborates with scholars based in United States, Canada and France. Kedar Inamdar's co-authors include Lawrence F. Povirk, Susan P. Lees‐Miller, Carlos E. Bueso‐Ramos, Jeffrey J. Pouliot, Aghdass Rasouli‐Nia, Tong Zhou, L. Jeffrey Medeiros, Ryan A. Wilcox, Carlos Murga‐Zamalloa and Mohamed E. Salama and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kedar Inamdar

39 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kedar Inamdar United States 15 393 276 253 156 141 39 772
Jennifer E. Amengual United States 15 574 1.5× 450 1.6× 408 1.6× 137 0.9× 214 1.5× 87 1.1k
Antonia Rodríguez Spain 10 269 0.7× 284 1.0× 179 0.7× 204 1.3× 99 0.7× 14 595
Giuseppe Dastoli Italy 15 251 0.6× 241 0.9× 284 1.1× 133 0.9× 154 1.1× 23 806
S. Öhl Germany 13 216 0.5× 378 1.4× 234 0.9× 264 1.7× 179 1.3× 19 778
Amanda Copeland United States 15 536 1.4× 558 2.0× 623 2.5× 315 2.0× 166 1.2× 36 1.2k
Barbara MacGregor‐Cortelli United States 10 605 1.5× 500 1.8× 424 1.7× 248 1.6× 198 1.4× 12 1.1k
Magdalena Klánová Czechia 12 231 0.6× 397 1.4× 346 1.4× 252 1.6× 130 0.9× 38 721
Junjiro Tsuchiyama Japan 14 252 0.6× 218 0.8× 271 1.1× 76 0.5× 303 2.1× 30 674
Luhong Sun United States 10 286 0.7× 207 0.8× 213 0.8× 146 0.9× 127 0.9× 19 564
J-Y Chen Taiwan 10 384 1.0× 330 1.2× 492 1.9× 28 0.2× 167 1.2× 12 914

Countries citing papers authored by Kedar Inamdar

Since Specialization
Citations

This map shows the geographic impact of Kedar Inamdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedar Inamdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedar Inamdar more than expected).

Fields of papers citing papers by Kedar Inamdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kedar Inamdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedar Inamdar. The network helps show where Kedar Inamdar may publish in the future.

Co-authorship network of co-authors of Kedar Inamdar

This figure shows the co-authorship network connecting the top 25 collaborators of Kedar Inamdar. A scholar is included among the top collaborators of Kedar Inamdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedar Inamdar. Kedar Inamdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rauf, Mohd Ahmar, Jonathan M. Weiss, Ira P. Maine, et al.. (2024). The GATA-3–dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas. Blood. 145(6). 597–611. 1 indexed citations
2.
Murga‐Zamalloa, Carlos, Ankit I. Mehta, Irum Khan, et al.. (2024). Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population. American Journal of Clinical Pathology. 161(6). 586–597. 1 indexed citations
3.
Gao, Xin, Chenguang Wang, Carlos Murga‐Zamalloa, et al.. (2022). Notch Signaling Promotes Mature T-Cell Lymphomagenesis. Cancer Research. 82(20). 3763–3773. 6 indexed citations
4.
Inamdar, Kedar, et al.. (2020). Should CD138 Immunohistochemistry be Standard Recommended Practice for Bone Marrow Evaluation of Plasma Cell Neoplasms?. American Journal of Clinical Pathology. 154(Supplement_1). S110–S110. 1 indexed citations
5.
Murga‐Zamalloa, Carlos, Delphine Rolland, Avery Polk, et al.. (2019). Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. Clinical Cancer Research. 26(3). 690–703. 48 indexed citations
6.
Murga‐Zamalloa, Carlos, Kedar Inamdar, & Ryan A. Wilcox. (2019). The role of aurora A and polo-like kinases in high-risk lymphomas. Blood Advances. 3(11). 1778–1787. 12 indexed citations
7.
Salama, Mohamed E., et al.. (2016). Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy. American Journal of Clinical Pathology. 145(4). 514–523. 32 indexed citations
9.
Kryvenko, Oleksandr N., et al.. (2015). Comparative Analysis Reveals Potential Utility of Digital Microscopy in the Evaluation of Peripheral Blood Smears With Some Barriers to Implementation. American Journal of Clinical Pathology. 144(1). 68–77. 7 indexed citations
10.
Kanagal‐Shamanna, Rashmi, Norman L. Lehman, Megan S. Lim, et al.. (2013). Differential expression of aurora-A kinase in T-cell lymphomas. Modern Pathology. 26(5). 640–647. 17 indexed citations
12.
Sharma, Gaurav, Michael D. Linden, Daniel Schultz, & Kedar Inamdar. (2009). Cystic tumor of the atrioventricular node: an unexpected finding in an explanted heart. Cardiovascular Pathology. 19(3). e75–e78. 9 indexed citations
14.
Inamdar, Kedar, Susan O’Brien, Subrata Sen, et al.. (2008). Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. Modern Pathology. 21(12). 1428–1435. 11 indexed citations
15.
Bircan, Sema, Kedar Inamdar, George Z. Rassidakis, & L. Jeffrey Medeiros. (2008). nm23-H1 Expression in non-Hodgkin and Hodgkin Lymphomas. Applied immunohistochemistry & molecular morphology. 16(3). 207–214. 4 indexed citations
16.
Inamdar, Kedar & Carlos E. Bueso‐Ramos. (2007). Pathology of chronic lymphocytic leukemia: an update. Annals of Diagnostic Pathology. 11(5). 363–389. 47 indexed citations
17.
Inamdar, Kedar, Jeffrey J. Pouliot, Tong Zhou, et al.. (2002). Conversion of Phosphoglycolate to Phosphate Termini on 3′ Overhangs of DNA Double Strand Breaks by the Human Tyrosyl-DNA Phosphodiesterase hTdp1. Journal of Biological Chemistry. 277(30). 27162–27168. 169 indexed citations
18.
Inamdar, Kedar, et al.. (2002). Resistance of 3′-Phosphoglycolate DNA Ends to Digestion by Mammalian DNase III. Radiation Research. 157(3). 306–311. 17 indexed citations
19.
20.
Chen, Shuang, Kedar Inamdar, Petra Pfeiffer, et al.. (2001). Accurate in Vitro End Joining of a DNA Double Strand Break with Partially Cohesive 3′-Overhangs and 3′-Phosphoglycolate Termini. Journal of Biological Chemistry. 276(26). 24323–24330. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026